Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study.

Autor:	Qi, Fei1, Wang, Wei-Hu2, He, Xiao-Hui1, Chen, Bo3, Gui, Lin1, Fang, Hui3, Liu, Peng1, Wang, Shu-Lian3, Yang, Jian-Liang1, Song, Yong-Wen3, Yang, Sheng1, Qi, Shu-Nan3, Zhou, Sheng-Yu1, Li, Ye-Xiong4 yexiong12@163.com, Dong, Mei1 dongmei030224@163.com
Zdroj:	International Journal of Radiation Oncology, Biology, Physics. Sep2018, Vol. 102 Issue 1, p61-70. 10p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu